Glenn Baity, EVP AND GC at ACADIA PHARMACEUTICALS INC (ACAD), sold 7,000 shares at $20.80 ($146K) on 2016-03-02, disclosed to the SEC on 2016-03-04.
Scheduled sale ($146k) by EVP AND GC under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ACAD | SELL | 2017-10-06 | $3.1M | — | Filing → |
| ACAD | SELL | 2017-09-01 | $924K | — | Filing → |
| ACAD | SELL | 2017-08-11 | $500K | — | Filing → |